FDA
Posaconazole
The FDA lists this product in 21 strengths and forms.
Composition
- Active ingredients
- POSACONAZOLE 100MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- POSACONAZOLE 100MG · Tablet, delayed releaseANDA212411-001 · Prescription
- POSACONAZOLE 300MG/16.7ML (18MG/ML) · SolutionANDA217553-001 · Prescription
- POSACONAZOLE 300MG/16.7ML (18MG/ML) · SolutionANDA211500-001 · Prescription
- POSACONAZOLE 100MG · Tablet, delayed releaseANDA212226-001 · Prescription
- POSACONAZOLE 100MG · Tablet, delayed releaseANDA207355-001 · Discontinued
- POSACONAZOLE 300MG/16.7ML (18MG/ML) · SolutionANDA208768-001 · Prescription
- POSACONAZOLE 300MG/16.7ML (18MG/ML) · SolutionANDA219057-001 · Prescription
- POSACONAZOLE 100MG · Tablet, delayed releaseANDA216488-001 · Prescription
- POSACONAZOLE 100MG · Tablet, delayed releaseANDA217119-001 · Prescription
- POSACONAZOLE 18MG · InjectionANDA217709-001 · Tentative approval
- POSACONAZOLE 100MG · Tablet, delayed releaseANDA216626-001 · Prescription
- POSACONAZOLE 100MG · Tablet, delayed releaseANDA212500-001 · Prescription
At a glance
- Brand name
- Posaconazole
- Route
- Oral
- Dosage form
- Tablet, delayed release
- Applicant
- Qilu Pharm Hainan
- Status
- Prescription
- FDA approval
- 23 Apr 2025
- Application
- ANDA217720-001



